课题基金 / 基金详情

Prostate cancer: Somatic genetics and novel therapeutics

Prostate cancer: Somatic genetics and novel therapeutics
前列腺癌：体细胞遗传学和新疗法
批准号：
174401
负责人：
Trifiro Mark A
金额：
$0.0万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-10-01 至 2009-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=174401&lang=en
关键词：
Animal Models Prostate Cancer Protein Structure And Function Somatic Genetics Systems Biology Therapeutics

项目摘要

项目成果

Trifiro Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer has become one of the most frequently diagnosed malignancies in men. Advanced prostate cancer can be a very lethal disorder. Prostate cancer is treated initially with hormonal therapy that lower androgen levels and blocks their action. Thi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.
Ultra-fast High Throughput Digital PCR Platform: Redefining Point-of-Care Diagnostics
Targeting novel BioNanofluids for prostate cancer therapy
海外基金